Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Despina Fotiou

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Annals of Hematology|March 6, 2019
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcomeGeorgia Trakada, Efstathios Kastritis, Maria Gavriatopoulou, et al.
Journal of Clinical Medicine|April 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical PracticeIoannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, et al.
Blood Cancer Journal|November 5, 2020
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patientsDespina Fotiou, Maria Roussou, Charikleia Gakiopoulou, et al.
Journal of Clinical Medicine|June 10, 2022
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 PatientsNikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia|July 21, 2018
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathiesTina Bagratuni, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Blood Vessels, Thrombosis & Hemostasis|March 11, 2026
On a quest for fingerprints of crystalglobulinemia on platelets and endotheliumVasiliki Gkalea, Panagiota-Efstathia Nikolaou, Thomas Pappas, et al.
Scandinavian Journal of Medicine & Science in Sports|January 24, 2025
Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First-Line TreatmentPolyxeni Spiliopoulou, Pantelis Rousakis, Chrysanthi Panteli, et al.
Sports (Basel, Switzerland)|February 26, 2026
Can Exercise Training Improve the Quality of Life and Physical Function in Multiple Myeloma Patients?: Discussing the Progression of the Training StimulusPolyxeni Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, et al.
American Journal of Hematology|June 22, 2022
Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implicationsEfstathios Kastritis, Magdalini Migkou, Dimitra Dalampira, et al.
British Journal of Haematology|September 16, 2021
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccineMaria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Annals of Hematology|March 6, 2019
Pulmonary function abnormalities are common in patients with multiple myeloma and are independently associated with worse outcomeGeorgia Trakada, Efstathios Kastritis, Maria Gavriatopoulou, et al.
Journal of Clinical Medicine|April 12, 2025
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical PracticeIoannis Ntanasis-Stathopoulos, Vassilis Koutoulidis, Panagiotis Malandrakis, et al.
Blood Cancer Journal|November 5, 2020
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patientsDespina Fotiou, Maria Roussou, Charikleia Gakiopoulou, et al.
Journal of Clinical Medicine|June 10, 2022
Newly Diagnosed Multiple Myeloma Patients with Skeletal-Related Events and Abnormal MRI Pattern Have Poor Survival Outcomes: A Prospective Study on 370 PatientsNikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Leukemia|July 21, 2018
Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathiesTina Bagratuni, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Blood Vessels, Thrombosis & Hemostasis|March 11, 2026
On a quest for fingerprints of crystalglobulinemia on platelets and endotheliumVasiliki Gkalea, Panagiota-Efstathia Nikolaou, Thomas Pappas, et al.
Scandinavian Journal of Medicine & Science in Sports|January 24, 2025
Effects of Exercise Training on the Bone Marrow Immune Microenvironment and Minimal Residual Disease in Multiple Myeloma Patients Following First-Line TreatmentPolyxeni Spiliopoulou, Pantelis Rousakis, Chrysanthi Panteli, et al.
Sports (Basel, Switzerland)|February 26, 2026
Can Exercise Training Improve the Quality of Life and Physical Function in Multiple Myeloma Patients?: Discussing the Progression of the Training StimulusPolyxeni Spiliopoulou, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, et al.
American Journal of Hematology|June 22, 2022
Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implicationsEfstathios Kastritis, Magdalini Migkou, Dimitra Dalampira, et al.
British Journal of Haematology|September 16, 2021
Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccineMaria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, et al.
Pageof 11